Defining the Molecular Point of Care (mPOC) Market in 2024

Defining the molecular point of care (mPOC) market is the first step in market-sizing this segment. The mPOC market refers to the use of molecular diagnostic tests at or near the patient’s location to enable rapid and actionable clinical decisions. These tests typically involve the detection of nucleic acids (DNA or RNA) from pathogens or […]

China: Molecular Point-of-Care’s International Market to Watch

Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]

Point-of-Care (POC) Diagnostic Testing: 5 Key Trends to Watch from 2022-2026

Globally, millions of dollars are spent annually on point-of-care (POC) diagnostic testing, both professional testing (which includes physician office labs, clinic labs, employer labs and hospital labs) and self-testing (which includes home, drug store testing and continuous glucose testing).  In 2021, amidst the pandemic, the POC market reached $41,149 million ($41.1 billion) and the market […]

Allergy Immunoassay Market at $612.5 Million with 30%-40% of World Population Affected

  Allergy statistics show that allergy conditions, triggered by anything from foods to venoms to vaccines and more, are constantly present in our lives and are not going away. In fact, the rising prevalence of allergies has created a market for allergy immunoassays—including lab-based allergy immunoassays and POC-based allergy immunoassays—that will reach an estimated $612.5 […]

China Emerging as Vital Point of Care (POC) Market

  Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information.   China’s potential as a point of care (POC) market was already growing when the coronavirus […]

At-Home Testing Expanding Reach Beyond COVID-19 Pandemic

Over the years, the increasing introduction of transportable, portable, and handheld medical instruments has resulted in the migration of point-of-care (POC) testing from the hospital environment to a range of medical and non-medical environments including the workplace, home, disaster care and most recently, convenience clinics. In the face of the ongoing global COVID-19 pandemic, the […]

Point of Care Test Market is Ravaged, and Helped By Pandemic

Kalorama Information reported a mixed result with point of care testing, defined by tests that can deliver a result meaningful during a patient visit with a provider or on their own.  In 2020, sales of POC testing reached $29,316 million, according to Kalorama Information, a sister publication to Lab Pulse.  That’s up double digits from […]